Authorization

LightDeck Diagnostics has $11 million for its new, high-speed, way to test for COVID-19, sepsis, and heart attack

LightDeck Diagnostics, a company formed earlier this year from the merger of startups mBio and Brava Diagnostics, has raised $11 million in funding for a new high-speed COVID-19 test, according to a statement.
The company’s novel test uses planar wave guide technologies to rapidly assess the presence of specific pathogens in a patient.
After collecting a patient sample, a user places the sample in a cartridge and then inserts that wave guide cartridge into the company’s proprietary analyzer. The sample mixes with a reagent pellet in the sample port where the substance is combined with a fluorescent molecule. After a predetermined amount of time, the sample-reagent mixture flows into the cartridge and combines with molecules that are printed as spots in an array on the wave guide cartridge.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2020    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
30